Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma adds William Crouse to board of directors

Comes as firm hopes to become global leader in biotechnology

EUSA Pharma has appointed William Crouse to its board of directors.

Crouse joins with 50 years of experience in the life sciences industry with his most recent role being general partner at Healthcare Venture, one of the world's largest venture capital firms specialising in biotechnology.

Prior to this, in his many roles over 30 years he has worked in the diagnostics industry, international operations, strategic planning, acquisitions, new product development and sales and marketing.

He said: “It's an honour to join EUSA and to help this ambitious company become a major force in the speciality field.

“Having worked with many of the EUSA team previously, I am confident the company has the capabilities and infrastructure in place to rapidly become a leading player in the sector.”

Bryan Morton, executive chairman at EUSA Pharma, said: “We have great ambitions for EUSA, and plan to grow our existing profitable business through acquisition and in-licensing.

“Bill's extensive experience and strategic insight will be a huge asset as we transform our business into a leading transatlantic speciality commercialization company.”

9th September 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics